Charles H. Sherwood
Chief Executive Officer
United States of America
Charles H. Sherwood, Ph.D. has been Chief Executive Officer of Anika Therapeutics since 2002. From 2002 through July 2017, he also held the title of President. Dr. Sherwood joined Anika in 1998 with extensive experience in research, engineering, manufacturing, quality assurance, regulatory affairs and business management. He first served at Anika in the position of Vice President of Research, Development and Engineering.
hyaluronic acid (HA), a naturally occurring biocompatible molecule found throughout the body that is a vital component of healthy joint and tissue function